IFN-α and IFN-β inhibit NLRP1-driven PANoptosis

Bhesh Raj Sharma1, Harisankeerth Mummareddy1, Sangappa B Chadchan1

  • 1Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.

EMBO Reports
|July 29, 2026
PubMed

Insights

Toll-like receptor 4 (TLR4) signaling inhibits NLRP1-mediated PANoptosis, a form of inflammatory cell death. This pathway involves TRIF and IRF3, leading to type I interferons that suppress NLRP1 expression.

Area of Science:

  • Immunology
  • Cellular Biology
  • Molecular Medicine

Background:

  • Innate immune sensors like NLRP1 detect cellular stress and pathogens, initiating inflammatory signaling and cell death.
  • Mutations in NLRP1 are linked to inflammatory diseases, yet its regulatory mechanisms remain unclear.

Purpose of the Study:

  • To investigate the regulation of NLRP1-mediated inflammatory cell death (PANoptosis).
  • To identify signaling pathways that modulate NLRP1 activity in response to innate immune activators.

Main Methods:

  • Utilized lipopolysaccharide (LPS) as a Toll-like receptor 4 (TLR4) ligand to activate innate immunity.
  • Assessed caspase activation, IL-18 release, and PANoptosis in response to LPS and interferons (IFNs).
  • Investigated the roles of TRIF, MyD88, and IRF3 in the signaling pathway.
  • Quantified NLRP1 expression in response to LPS and type I IFNs in murine and human immune cells.

Main Results:

  • LPS inhibits NLRP1-mediated PANoptosis, caspase activation, and IL-18 release.
  • This inhibition is dependent on TRIF and IRF3, indicating a role for TRIF-dependent TLR4 signaling and type I IFN signaling.
  • Type I IFNs (IFN-α, IFN-β) directly inhibit NLRP1-dependent PANoptosis in macrophages and monocytes.
  • LPS and type I IFNs significantly reduce NLRP1 and Nlrp1b expression at the transcriptional level.

Conclusions:

  • A TLR4-TRIF-IRF3 signaling axis induces type I IFNs, which suppress NLRP1 transcription.
  • This negative feedback loop blocks NLRP1-driven PANoptosis, involving caspase-1, caspase-8, and RIPK3.
  • Type I IFNs represent a potential therapeutic target for managing NLRP1-associated inflammatory diseases.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...